{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:33:09Z","timestamp":1791981189266,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1186\/s13075-014-0463-7","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T10:23:54Z","timestamp":1413282234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Ann","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary O","family":"Whipple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto P","family":"Benzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"463_CR1","unstructured":"Fibromyalgia: poorly understood; treatments are disappointing.Prescrire Int 2009, 18:169-173.,"},{"key":"463_CR2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/mcp.2011.0206","volume":"86","author":"DJ Clauw","year":"2011","unstructured":"Clauw DJ, Arnold LM, McCarberg BH: The science of fibromyalgia. Mayo Clin Proc. 2011, 86: 907-911. 10.4065\/mcp.2011.0206.","journal-title":"Mayo Clin Proc"},{"key":"463_CR3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010, 62: 600-610. 10.1002\/acr.20140.","journal-title":"Arthritis Care Res"},{"key":"463_CR4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2474-11-134","volume":"11","author":"RM Bennett","year":"2010","unstructured":"Bennett RM, Russell J, Cappelleri JC, Bushmakin AG, Zlateva G, Sadosky A: Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. BMC Musculoskelet Disord. 2010, 11: 134-10.1186\/1471-2474-11-134.","journal-title":"BMC Musculoskelet Disord"},{"key":"463_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-008-0722-5","volume":"29","author":"JB de Souza","year":"2009","unstructured":"de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S: Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire: a preliminary study. Rheumatol Int. 2009, 29: 509-515. 10.1007\/s00296-008-0722-5.","journal-title":"Rheumatol Int"},{"key":"463_CR6","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/art.11272","volume":"48","author":"T Giesecke","year":"2003","unstructured":"Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, Gracely RH, Clauw DJ: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003, 48: 2916-2922. 10.1002\/art.11272.","journal-title":"Arthritis Rheum"},{"key":"463_CR7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10067-011-1912-1","volume":"31","author":"BL Loevinger","year":"2012","unstructured":"Loevinger BL, Shirtcliff EA, Muller D, Alonso C, Coe CL: Delineating psychological and biomedical profiles in a heterogeneous fibromyalgia population using cluster analysis. Clin Rheumatol. 2012, 31: 677-685. 10.1007\/s10067-011-1912-1.","journal-title":"Clin Rheumatol"},{"key":"463_CR8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/NNR.0b013e3181b499d2","volume":"58","author":"DN Rutledge","year":"2009","unstructured":"Rutledge DN, Mouttapa M, Wood PB: Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res. 2009, 58: 359-367. 10.1097\/NNR.0b013e3181b499d2.","journal-title":"Nurs Res"},{"key":"463_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2009\/137901","volume":"14","author":"ML Verra","year":"2009","unstructured":"Verra ML, Angst F, Brioschi R, Lehmann S, Keefe FJ, Staal JB, de Bie RA, Aeschlimann A: Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?. Pain Res Manag. 2009, 14: 445-453.","journal-title":"Pain Res Manag"},{"key":"463_CR10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.24163","volume":"61","author":"HD Wilson","year":"2009","unstructured":"Wilson HD, Robinson JP, Turk DC: Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum. 2009, 61: 527-534. 10.1002\/art.24163.","journal-title":"Arthritis Rheum"},{"key":"463_CR11","doi-asserted-by":"crossref","first-page":"e74873","DOI":"10.1371\/journal.pone.0074873","volume":"8","author":"E Docampo","year":"2013","unstructured":"Docampo E, Collado A, Escaram\u00eds G, Carbonell J, Rivera J, Vidal J, Alegre J, Rabionet R, Estivill X: Cluster analysis of clinical data identifies fibromyalgia subgroups. PLoS One. 2013, 8: e74873-10.1371\/journal.pone.0074873.","journal-title":"PLoS One"},{"key":"463_CR12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/art.1790110511","volume":"11","author":"DC Turk","year":"1998","unstructured":"Turk DC, Okifuji A, Sinclair JD, Starz TW: Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res. 1998, 11: 397-404. 10.1002\/art.1790110511.","journal-title":"Arthritis Care Res"},{"key":"463_CR13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/art.23826","volume":"59","author":"PJ Mease","year":"2008","unstructured":"Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum. 2008, 59: 952-960. 10.1002\/art.23826.","journal-title":"Arthritis Rheum"},{"key":"463_CR14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/cts.12056","volume":"6","author":"MO Whipple","year":"2013","unstructured":"Whipple MO, McAllister SJ, Oh TH, Luedtke CA, Toussaint LL, Vincent A: Construction of a US fibromyalgia registry using the Fibromyalgia Research Survey criteria. Clin Trans Sci. 2013, 6: 398-399. 10.1111\/cts.12056.","journal-title":"Clin Trans Sci"},{"key":"463_CR15","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM: Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994, 23: 129-138.","journal-title":"Ann Acad Med Singapore"},{"key":"463_CR16","volume-title":"EdITS Manual for the Profile of Mood States","author":"DM McNair","year":"1992","unstructured":"McNair DM, Lorr M, Droppleman LF: EdITS Manual for the Profile of Mood States. 1992, Educational and Industrial Testing Service, San Diego, CA"},{"key":"463_CR17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.sleep.2008.09.004","volume":"10","author":"JC Cappelleri","year":"2009","unstructured":"Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S: Measurement properties of the medical outcomes study sleep scale in patients with fibromyalgia. Sleep Med. 2009, 10: 766-770. 10.1016\/j.sleep.2008.09.004.","journal-title":"Sleep Med"},{"key":"463_CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995, 39: 315-325. 10.1016\/0022-3999(94)00125-O.","journal-title":"J Psychosom Res"},{"key":"463_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/01688639408402620","volume":"16","author":"M Seidenberg","year":"1994","unstructured":"Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A: Development and validation of a Multiple Ability Self-Report Questionnaire. Clin Exp Neuropsychol. 1994, 16: 93-104. 10.1080\/01688639408402620.","journal-title":"Clin Exp Neuropsychol"},{"key":"463_CR20","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL: The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009, 11: R120-10.1186\/ar2783.","journal-title":"Arthritis Res Ther"},{"key":"463_CR21","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware Jr","year":"2000","unstructured":"Ware JE: SF-36 health survey update. Spine. 2000, 25: 3130-3139. 10.1097\/00007632-200012150-00008.","journal-title":"Spine"},{"key":"463_CR22","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1002\/acr.20531","volume":"63","author":"DA Williams","year":"2011","unstructured":"Williams DA, Arnold LM: Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ). Arthritis Care Res. 2011, 63: S86-S97. 10.1002\/acr.20531.","journal-title":"Arthritis Care Res"},{"key":"463_CR23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, H\u00e4user W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB: Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011, 38: 1113-1122. 10.3899\/jrheum.100594.","journal-title":"J Rheumatol"},{"key":"463_CR24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1557988312436872","volume":"6","author":"VA Aparicio","year":"2012","unstructured":"Aparicio VA, Ortega FB, Carbonell-Baeza A, Femia P, Tercedor P, Ruiz JR, Delgado-Fern\u00e1ndez M: Are there gender differences in quality of life and symptomatology between fibromyalgia patients?. Am J Mens Health. 2012, 6: 314-319. 10.1177\/1557988312436872.","journal-title":"Am J Mens Health"},{"key":"463_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/sarh.2000.8363","volume":"30","author":"D Buskila","year":"2000","unstructured":"Buskila D, Neumann L, Alhoashle A, Abu-Shakra M: Fibromyalgia syndrome in men. Semin Arthritis Rheum. 2000, 30: 47-51. 10.1053\/sarh.2000.8363.","journal-title":"Semin Arthritis Rheum"},{"key":"463_CR26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1526-4637.2012.01523.x","volume":"13","author":"AM Castro-S\u00e1nchez","year":"2012","unstructured":"Castro-S\u00e1nchez AM, Matar\u00e1n-Pe\u00f1arrocha GA, L\u00f3pez-Rodr\u00edguez MM, Lara-Palomo IC, Arendt-Nielsen L, Fern\u00e1ndez-de-las-Pe\u00f1as C: Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med. 2012, 13: 1639-1647. 10.1111\/j.1526-4637.2012.01523.x.","journal-title":"Pain Med"},{"key":"463_CR27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1526-4637.2006.00202.x","volume":"8","author":"WM Hooten","year":"2007","unstructured":"Hooten WM, Townsend CO, Decker PA: Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med. 2007, 8: 624-632. 10.1111\/j.1526-4637.2006.00202.x.","journal-title":"Pain Med"},{"key":"463_CR28","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3899\/jrheum.090367","volume":"36","author":"P Mease","year":"2009","unstructured":"Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA: Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol. 2009, 36: 2318-2329. 10.3899\/jrheum.090367.","journal-title":"J Rheumatol"},{"key":"463_CR29","volume-title":"The Brief Pain Inventory: User Guide","author":"CS Cleeland","year":"2009","unstructured":"Cleeland CS: The Brief Pain Inventory: User Guide. 2009, Charles S Cleeland, Houston, TX"},{"key":"463_CR30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D\u2019Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119: 5-15. 10.1016\/j.pain.2005.06.031.","journal-title":"Pain"},{"key":"463_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/IJGM.S3979","volume":"1","author":"AS Chappell","year":"2008","unstructured":"Chappell AS, Bradley LA, Wiltse C, Detke MJ, D\u2019Souza DN, Spaeth M: A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia. Int J Gen Med. 2008, 1: 91-102. 10.2147\/IJGM.S3979.","journal-title":"Int J Gen Med"},{"key":"463_CR32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20449","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, Kajdasz DK, Walker DJ, Chappell AS: Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res. 2011, 63: 821-826. 10.1002\/acr.20449.","journal-title":"Arthritis Care Res"},{"key":"463_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008, 136: 432-444. 10.1016\/j.pain.2008.02.024.","journal-title":"Pain"},{"key":"463_CR34","first-page":"355","volume":"33","author":"A Bourgeois","year":"2010","unstructured":"Bourgeois A, LeUnes A, Meyers M: Full-scale and short-form of the Profile of Mood States: a factor analytic comparison. J Sport Behav. 2010, 33: 355-376.","journal-title":"J Sport Behav"},{"key":"463_CR35","first-page":"463","volume":"5","author":"K Malin","year":"2012","unstructured":"Malin K, Littlejohn GO: Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. J Pain Res. 2012, 5: 463-471.","journal-title":"J Pain Res"},{"key":"463_CR36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.rhu.0000120895.20623.9f","volume":"10","author":"RS Katz","year":"2004","unstructured":"Katz RS, Heard AR, Mills M, Leavitt F: The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol. 2004, 10: 53-58. 10.1097\/01.rhu.0000120895.20623.9f.","journal-title":"J Clin Rheumatol"},{"key":"463_CR37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","volume":"9","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U, Martin SA, Barrett JA, Haig G: A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008, 9: 792-805. 10.1016\/j.jpain.2008.03.013.","journal-title":"J Pain"},{"key":"463_CR38","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"LJ Crofford","year":"2005","unstructured":"Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP, LaMoreaux LK, Martin SA, Sharma U: Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005, 52: 1264-1273. 10.1002\/art.20983.","journal-title":"Arthritis Rheum"},{"key":"463_CR39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1477-7525-7-64","volume":"7","author":"S Martin","year":"2009","unstructured":"Martin S, Chandran A, Zografos L, Zlateva G: Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes. 2009, 7: 64-10.1186\/1477-7525-7-64.","journal-title":"Health Qual Life Outcomes"},{"key":"463_CR40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1478-7954-7-18","volume":"7","author":"JMS Lin","year":"2009","unstructured":"Lin JMS, Brimmer DJ, Maloney EM, Nyarko E, BeLue R, Reeves WC: Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr. 2009, 7: 18-10.1186\/1478-7954-7-18.","journal-title":"Popul Health Metr"},{"key":"463_CR41","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","volume":"30","author":"DJ Clauw","year":"2008","unstructured":"Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y: Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008, 30: 1988-2004. 10.1016\/j.clinthera.2008.11.009.","journal-title":"Clin Ther"},{"key":"463_CR42","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar3359","volume":"13","author":"LM Arnold","year":"2011","unstructured":"Arnold LM, Wang F, Ahl J, Gaynor PJ, Wohlreich MM: Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: Secondary analysis of a randomized, placebo-controlled trial. Arthritis Res Ther. 2011, 13: R86-10.1186\/ar3359.","journal-title":"Arthritis Res Ther"},{"key":"463_CR43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1358\/dot.2008.44.9.1256003","volume":"44","author":"RT Owen","year":"2008","unstructured":"Owen RT: Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome. Drugs Today (Barc). 2008, 44: 653-660. 10.1358\/dot.2008.44.9.1256003.","journal-title":"Drugs Today (Barc)"},{"key":"463_CR44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","volume":"39","author":"JC Branco","year":"2010","unstructured":"Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caub\u00e8re JP, Le Lay K, Taieb C, Matucci-Cerinic M: Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010, 39: 448-453. 10.1016\/j.semarthrit.2008.12.003.","journal-title":"Semin Arthritis Rheum"},{"key":"463_CR45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","volume":"36","author":"PJ Mease","year":"2009","unstructured":"Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH: The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009, 36: 398-409. 10.3899\/jrheum.080734. A published erratum appears in J Rheumatol 2009, 36:661","journal-title":"J Rheumatol"},{"key":"463_CR46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(01)01089-0","volume":"112","author":"LM Arnold","year":"2002","unstructured":"Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE: A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002, 112: 191-197. 10.1016\/S0002-9343(01)01089-0.","journal-title":"Am J Med"},{"key":"463_CR47","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/art.27559","volume":"62","author":"LM Arnold","year":"2010","unstructured":"Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y: Efficacy and safety of milnacipran 100 mg\/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010, 62: 2745-2756. 10.1002\/art.27559.","journal-title":"Arthritis Rheum"},{"key":"463_CR48","first-page":"365","volume":"27","author":"D Da Costa","year":"2000","unstructured":"Da Costa D, Dobkin PL, Fitzcharles MA, Fortin PR, Beaulieu A, Zummer M, Sen\u00e9cal JL, Goulet JR, Rich E, Choquette D, Clarke AE: Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol. 2000, 27: 365-372.","journal-title":"J Rheumatol"},{"key":"463_CR49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/sarh.2000.7171","volume":"29","author":"L Neumann","year":"2000","unstructured":"Neumann L, Berzak A, Buskila D: Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the Short Form 36-item health survey (SF-36). Semin Arthritis Rheum. 2000, 29: 400-408. 10.1053\/sarh.2000.7171.","journal-title":"Semin Arthritis Rheum"},{"key":"463_CR50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/09638280310001639696","volume":"26","author":"EH T\u00fcz\u00fcn","year":"2004","unstructured":"T\u00fcz\u00fcn EH, Albayrak G, Eker L, S\u00f6zay S, Da\u015fkapan A: A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome. Disabil Rehabil. 2004, 26: 198-202. 10.1080\/09638280310001639696.","journal-title":"Disabil Rehabil"},{"key":"463_CR51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, Decker O, M\u00fcller S, Br\u00e4hler E, Schellberg D, Herzog W, Herzberg PY: Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008, 46: 266-274. 10.1097\/MLR.0b013e318160d093.","journal-title":"Med Care"},{"key":"463_CR52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166: 1092-1097. 10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"key":"463_CR53","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1002\/acr.20556","volume":"63","author":"KL Smarr","year":"2011","unstructured":"Smarr KL, Keefer AL: Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res. 2011, 63: S454-S466. 10.1002\/acr.20556.","journal-title":"Arthritis Care Res"},{"key":"463_CR54","unstructured":"R: A Language and Environment for Statistical Computing. 2012, R Foundation for Statistical Computing, Vienna, Austria"},{"key":"463_CR55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-9-71","volume":"9","author":"C Schaefer","year":"2011","unstructured":"Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G: The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011, 9: 71-10.1186\/1477-7525-9-71.","journal-title":"Health Qual Life Outcomes"},{"key":"463_CR56","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3899\/jrheum.110026","volume":"38","author":"B Walitt","year":"2011","unstructured":"Walitt B, Fitzcharles MA, Hassett AL, Katz RS, H\u00e4user W, Wolfe F: The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011, 38: 2238-2246. 10.3899\/jrheum.110026.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-014-0463-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0463-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:15:37Z","timestamp":1559618137000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0463-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0463-7","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]},"article-number":"463"}}